Skip to content
Disclosery

JOHNSON & JOHNSON

Follow

13F filer, CIK 200406, NEW BRUNSWICK, NJ

JOHNSON & JOHNSON reported $798,650,757 across 15 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-06. Its ten largest share positions make up 98.41% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000904454-26-000435

Period
2026-06-30
Reported value
$799M
Holdings
15
Top 10 weight
98.41%
New
1
Sold out
2

Part of the filer group JOHNSON & JOHNSON

How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CBRSnew+53,586$11.8M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
RLYBexited-152,901-$1.37M
NNOXexited-83,554-$190K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0000904454-26-000435, largest first. % of portfolio is the value over $798,650,757, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: 2,449,183 shares; 2025Q4: 2,449,183 shares; 2026Q1: 2,449,183 shares; 2026Q2: 2,449,183 shares 2,449,183$300M37.59%0Timeline
NBTXNANOBIOTIXQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: 5,623,816 shares; 2025Q4: 5,623,816 shares; 2026Q1: 5,623,816 shares; 2026Q2: 5,623,816 shares 5,623,816$212M26.55%0Timeline
MGTXMEIRAGTX HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: 6,641,064 shares; 2025Q4: 6,641,064 shares; 2026Q1: 6,641,064 shares; 2026Q2: 6,641,064 shares 6,641,064$89.7M11.23%0Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: 1,784,517 shares; 2025Q4: 1,784,517 shares; 2026Q1: 1,784,517 shares; 2026Q2: 1,784,517 shares 1,784,517$74.4M9.31%0Timeline
CTNMCONTINEUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: 1,979,173 shares; 2025Q4: 1,979,173 shares; 2026Q1: 1,979,173 shares; 2026Q2: 1,979,173 shares 1,979,173$32.4M4.06%0Timeline
LEGNLEGEND BIOTECH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: 814,586 shares; 2025Q4: 814,586 shares; 2026Q1: 814,586 shares; 2026Q2: 814,586 shares 814,586$23.5M2.95%0Timeline
CVRXCVRX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: 4,103,430 shares; 2025Q4: 4,024,861 shares; 2026Q1: 4,024,861 shares; 2026Q2: 4,024,861 shares 4,024,861$20.7M2.59%0Timeline
XNCRXENCOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: 748,062 shares; 2025Q4: 748,062 shares; 2026Q1: 748,062 shares; 2026Q2: 748,062 shares 748,062$12M1.51%0Timeline
CBRSCEREBRAS SYSTEMS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 53,586 shares 53,586$11.8M1.48%newTimeline
FATEFATE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: 3,379,064 shares; 2025Q4: 3,379,064 shares; 2026Q1: 3,379,064 shares; 2026Q2: 3,379,064 shares 3,379,064$9.12M1.14%0Timeline
PRCTPROCEPT BIOROBOTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: 357,939 shares; 2025Q4: 357,939 shares; 2026Q1: 357,939 shares; 2026Q2: 357,939 shares 357,939$8.08M1.01%0Timeline
NMRANEUMORA THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: 1,849,445 shares; 2025Q4: 1,849,445 shares; 2026Q1: 1,849,445 shares; 2026Q2: 1,849,445 shares 1,849,445$3.14M0.39%0Timeline
VORVOR BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not reported; 2025Q4: 53,732 shares; 2026Q1: 53,732 shares; 2026Q2: 53,732 shares 53,732$989K0.12%0Timeline
LABSTANDARD BIOTOOLS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: 311,967 shares; 2025Q4: 311,967 shares; 2026Q1: 311,967 shares; 2026Q2: 311,967 shares 311,967$257K0.03%0Timeline
ACETADICET BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not reported; 2025Q4: 22,779 shares; 2026Q1: 22,779 shares; 2026Q2: 22,779 shares 22,779$197K0.02%0Timeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
RLYBRALLYBIO CORP152,901$1.37Mshares
NNOXNANO X IMAGING LTD83,554$190Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000904454-26-000435 base2026-08-06acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0000904454-26-000435 Quarter ended 2026-06-302026-08-06acceptance time not in the bulk data set
13F-HR 0000904454-26-000280 Quarter ended 2026-03-312026-05-13acceptance time not in the bulk data set
13F-HR/A 0000904454-26-000192 Quarter ended 2025-12-312026-03-18acceptance time not in the bulk data set
13F-HR/A 0000904454-26-000190 Quarter ended 2025-09-302026-03-18acceptance time not in the bulk data set